WHETHER THAT NEW YORK VARIANT POSES A GREATER RISK TO
HUMANS.
LESTER.
HUMANS. LESTER. >>> PFIZER IS
PARTNERED WITH
BIONTECH.
I SPOKE ABOUT IT WITH
THE PFIZER’S CEO, IF
SOMEONE HAD TWO DOSES
OF YOUR VACCINE, ARE
THEY PROTECTED FROM
ANY OF THE VIRUS SF?
>> NOW, WE HAVE
CONFIRMATIONS THAT
THEY ARE PROTECTED
FROM THE U.K. VARIANT
AND WE HAVE DATA OF
PROTECTION AGAINST THE
SOUTH AFRICAN AND THE
BRAZILIAN VIRUS.
>> PFIZER ANNOUNCED TO
TEST A BOOSTER
POTENTIALLY AN ANNUAL
THIRD DOSE TO FIGHT
THE NEW VARIANT.
>> DO YOU THINK IT
WILL BE EFFECTIVE AND
LAST LONGER?
>> WEM RAISE THE
ANTIBODY RESPONSE
RIGHT NOW.
THAT’LL BE SIGNIFICANT
TO OVERCOME ALL THESE
RESISTANCE OF WHAT WE
KNOW SO FAR.
ALSO, I WANT TO SAY
THIS IS A TWO-DOSE
VACCINE FOR THE
INITIATION OF THE
SCHEDULE.
>> IS THERE
EXPECTATION THAT THIS
WILL TURN INTO A
ROUTINE THREE-DOSE
VACCINATION.
>> THE COMPANY
ANNOUNCED IS WORKING
WITH REGULATORS ON
POTENTIAL CHANGES TO
ITS VACCINE COULD MAKE
IT ADAPTABLE TO FUTURE
VARIANTS.
>> HOW LONG FROM THE
TIME YOU DISCOVER A
NEW VARIANT COULD YOU
TWEET YOUR CURRENT
VACCINE
VACCINES TO MAKE IT
EFFECTIVE?
>> WE ARE AIMING FOR
100 DAYS.
>> WHAT ABOUT THE
FINDINGS OF ISRAELI
STUDIES SHOWING
SUBSTANTIAL IMMUNE
RESPONSE AFTER ONE
DOSE OF THE PFIZER
VACCINE.
>> I BELIEVE THE DATA
WERE IN MUCH YOUNGER
POPULATION SO YOU
EXPECT MUCH HIGHER
LEVEL OF PROTECTION.
>> IT IS TOO MUCH OF A
REUSING RIGHT NOW TO
RELY ON ONE DOSE.
>> VERY HIGH RISK, I
THINK.
>> PEOPLE GETTING
THESE VACCINATIONS
WITH THE HOPES THAT
THEY WON’T DIE AND GET
SICK FROM THE DISEASE.
AND RIGHT NOW WE ARE
STILL WEARING MASKS
BECAUSE OF THE
POSSIBILITY THAT YOU
CAN STILL INFECT
OTHERS.
WHAT IS THE DATA
SHOWING YOU?
IS IT LIKELY THAT YOU
CAN INFECT OTHERS
AFTER TWO DOSES?
>> WE ARE GETTING DATA
AND OTHER STUDIES WILL
BETTER UNDERSTAND
THIS.
A LOT OF INDICATIONS
RIGHT NOW THAT ARE
TELLING US THAT THERE
IS A PROTECTION
AGAINST TRANSMISSION.
>> STUDIES ARE
UNDERWAY WITH PREGNANT
WOMEN AND THEY HAVE
NOT SEEN ANY ISSUES.
THEY ARE OPTIMISTIC OF
THEIR PEDIATRIC
VACCINE TRIAL.
>> HOW SOON MAY WE SEE
VACCINATIONS FOR YOUNG
CHILDREN?
>> WE ARE ALREADY
DOING TRIALS FOR KIDS
BETWEEN 11 AND 12
YEARS OLDS AND ALL THE
WAY TO 16.
I HOPE WE’LL HAVE DATA
IN A COUPLE OF MONTHS.
I BELIEVE WE SHOULD
HAVE DATA ABOUT THIS
BY THE END OF THE
YEAR.
>> THE QUESTION ON ALL
OUR MINDS.
CURRENTLY WITH THE TWO
DOSE VACCINES, HOW
LONG DOES THAT EXTEND
PROTECTION GOING
FORWARD?
>> WE DON’T KNOW NOW,
LESTER BECAUSE WE HAVE
ONLY TAKEN ON FOR SIX
MONTHS.
AFTER SIX MONTHS, THE
PROTECTION IS ROBUST.
WE HAVE TO WAIT AND
SEE IN ONE YEAR.
>> THE FDA GAVE THE
OKAY FOR PFIZER
VACCINES TO BE SHIPPED
AND STORED IN
CONVENTIONAL COLD